jeudi 10 janvier 2019

Onco Actu du 10 janvier 2019


1.4 BIOLOGIE - TECHNOS



Commentary: Attacking Biology’s Complexity with New Genomics Approaches [Fortune]











2.11 ETIOLOGIE - ALIMENTATION



Artificial Sweeteners, Not Good, Not Bad [NY Times]











2.5 ETIOLOGIE - GÈNES



BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk [NCI]










5. TRAITEMENTS



Protein found more in advanced prostate cancer could be key to preventing drug resistance [Institute of Cancer Research]











Sponge offers hope of 'less toxic' chemotherapy [BBC News]











5.1 TRAITEMENTS - PRÉ-CLINIQUE



Designer protein delivers signal of choice [Nature]










Scientists design protein that prods cancer-fighting T-cells [UW Medicine]











Researchers redesign a cancer-busting protein—without the side effects [Science]











5.12 IMMUNOTHÉRAPIES



Immunotherapy Effective in Alveolar Soft Part Sarcoma [NCI]











5.12.1 IMMUNOTHÉRAPIES - PARTENARIATS



What The Software Ordered: New Partnership Pairs AI, Immunotherapy To Boost Odds For Beating Cancer [GE]











5.12.7 IMMUNOTHÉRAPIES - VACCINS



Progress in the fight against brain cancer [Nature]










5.12.8 IMMUNOTHÉRAPIES - ECONOMIE



Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer [NICE]










Bluebird endorses plan for installment-based payments for costly gene therapy [EndPoints]











5.2 PHARMA



Rewiring R&D: The FierceBiotech JPM 2019 breakfast debate [Fierce Biotech]











Novartis puts AI on the job to help reps say the right things to the right doctors [Fierce Pharma]











5.2.1 PHARMA - PARTENARIATS



Basilea posts interim pivotal data on ArQule-partnered cancer drug [Fierce Biotech]











Cancer Research UK, NIHR and Athenex to trial innovative oral chemotherapy [Cancer Research UK]











5.3 TRAITEMENTS - FDA, EMA, NICE...



EU Medicines Agency picks up its roots, embracing Amsterdam [STAT]











5.4 TRAITEMENTS - ECONOMIE



Stivarga final NICE recommendation for hepatocellular carcinoma [Pharma Times]











Regorafenib for previously treated advanced hepatocellular carcinoma [NICE]










6. LUTTE CONTRE LES CANCERS



Gauging Progress Against Cervical Cancer [Cancer Research Catalyst]










6.1 OBSERVATION



Statement from American Society of Clinical Oncology (ASCO) President Monica M. Bertagnolli, MD, FACS, FASCO, on the American Cancer Society Cancer Facts and Figures 2019 Report [ASCO]











Cancer Death Rate Continues to Decline [Science-Based Medicine]










6.10 POLITIQUES



EU survey 2018 [BMA]











6.10.1 POLITIQUES (USA)



The first patient has been treated under the controversial “right to try” law [EndPoints]